Company news
Exelixis, Inc. news in 2019
Exelixis, Inc.'s news releases, calls and decks from 2019, newest first.
Exelixis Enters into a Clinical Collaboration for Three Phase 3 Combination Trials for Patients with Advanced Solid Tumors
December 18, 2019
Exelixis Announces Positive Results From IMspire150, the Phase 3 Trial of Atezolizumab Plus Cotellic and Vemurafenib in People With Previously Untreated BRAF V600 Mutation-Positive Advanced Melanoma
December 12, 2019
Exelixis Announces Third Quarter 2019 Financial Results and Provides Corporate Update
October 29, 2019
Exelixis to Release Third Quarter 2019 Financial Results on Wednesday, October 30, 2019
October 15, 2019
Exelixis Announces Second Quarter 2019 Financial Results and Provides Corporate Update
July 30, 2019